ePrints

Preclinical evaluation of the POLY-ADP ribose polymerase 1 (PARP-1) inhibitor AG014699 in combination with topotecan and temozolomide for the treatment of medulloblastoma and neuroblastoma

Lookup NU author(s): Professor Steven CliffordORCiD, Rachel Daniel, Dr Agata Rozanska, Huw ThomasORCiD, Professor Alan Boddy, Professor Deborah Tweddle, Professor Nicola CurtinORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Clifford S, Daniel R, Rozanska A, Thomas HD, Boddy AV, Tweddle DA, Curtin NJ

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 39th International Conference of the International Society for Pediatric Oncology

Year of Conference: 2007

Pages: 434-435 O.133

Publisher: Pediatric Blood and Cancer

URL: http://dx.doi.org/10.1002/pbc.21342

DOI: 10.1002/pbc.21342

Library holdings: Search Newcastle University Library for this item

ISBN:

Share